118 results
Page 3 of 6
8-K
EX-2.1
uz2nz
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.2
4w6e2pk4 lf
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-99.1
a5d97y2d rarnbi
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
diy2bl35
8 Nov 19
Recro Pharma Reports Third Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
u78 2jhymokpkrijo7fz
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
q843k5aj
8 Aug 19
Recro Pharma Reports Second Quarter 2019 Financial Results
7:58am
8-K
EX-99.1
orfjinpm yts
10 May 19
Recro Pharma Reports First Quarter 2019 Financial Results
7:05am
8-K
EX-99.1
c5rxma 1nbo
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-10.1
cn78n7a8hc9vb01oht5
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
31aapv6pddy
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
2sl o0b1rw7
22 Mar 19
Recro Pharma Receives Complete Response Letter from the FDA for Intravenous Meloxicam
4:17pm